| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $211K | -12.1% | +174.0% |
| R&D Expense | $4.5M | -39.5% | +378.2% |
| SG&A Expense | $2.3M | -20.0% | -12.4% |
| Operating Income | -$6.7M | +34.4% | -0.2% |
| Pre-tax Income | -$6.3M | +35.8% | -18.3% |
| Income Tax | $48K | +380.0% | +140.0% |
| Net Income | -$6.4M | +34.6% | -38.3% |
| EPS (Basic) | -$0.13 | +31.6% | +31.6% |
| EPS (Diluted) | -$0.13 | +31.6% | +31.6% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $37.8M | -17.0% | -21.8% |
| Accounts Receivable | $295K | -28.6% | +47.5% |
| Inventory | $271K | -0.4% | — |
| Current Assets | $42.4M | -12.2% | -35.5% |
| Total Assets | $99.3M | -5.8% | +19.6% |
| Current Liabilities | $12.4M | +2.3% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.3M | -110.5% | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$685K | -59.3% | — |
| Financing Cash Flow | -$62K | -106.7% | — |
| Free Cash Flow | -$14.3M | — | — |
| +73.8% |
| Total Liabilities | $16.1M | -0.9% | +53.2% |
| Stockholders' Equity | $79.2M | -7.1% | +14.1% |